Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on APONTIS PHARMA AG (DE:APPH – Research Report), Roche Holding AG (RHHVF – Research Report) and Zur Rose Group AG (CH:DOCM – Research Report).
APONTIS PHARMA AG (DE:APPH)
In a report issued on April 12, Christian Ehmann from Warburg Research maintained a Buy rating on APONTIS PHARMA AG, with a price target of EUR20.00. The company’s shares closed last Tuesday at EUR8.22.
Ehmann has an average return of
According to TipRanks.com, Ehmann is ranked #7723 out of 8783 analysts.
APONTIS PHARMA AG has an analyst consensus of Moderate Buy, with a price target consensus of EUR20.00.
See Insiders’ Hot Stocks on TipRanks >>
Roche Holding AG (RHHVF)
Berenberg Bank analyst Luisa Hector maintained a Hold rating on Roche Holding AG on March 8 and set a price target of CHF265.00. The company’s shares closed last Tuesday at $243.50, close to its 52-week low of $237.81.
According to TipRanks.com, Hector is a 4-star analyst with an average return of
Roche Holding AG has an analyst consensus of Hold, with a price target consensus of $273.68, a 14.6% upside from current levels. In a report issued on February 22, UBS also maintained a Hold rating on the stock with a CHF248.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
